We are looking for children to join a Crohn’s disease research study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or UC (including associated symptoms such as cramps, blood in the stool, rectal pain, frequent fevers and/or liver disease), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s flare-ups? Local CD medical research study is testing a potential new medication to see if it may reduce abdominal pain or cramping, fever, abdominal pain, chronic fatigue, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the CD medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local clinical research is testing a potential new medication to see if it may reduce abdominal pain and cramps, fistula, cramps, malnutrition, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe IBD flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce abdominal pain, fatigue, diarrhea, frequent fevers, and/or liver disease associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for teen to join a Crohn’s disease trial to help us discover more about treating ulcerative colitis (UC). If you are looking for a potential new treatment option for ulcerative colitis (UC) or moderate to severe UC (including associated symptoms such as chronic diarrhea, perianal fistula, constant need to poop, weight loss and/or canker sores), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce abdominal pain and cramps, growth failure, diarrhea, weight loss, and/or eye pain associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing IBD flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce recurrent diarrhea, iron deficiency, bloody stool, weight loss, and/or liver disease associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe CD flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce weight loss, iron deficiency, diarrhea, malnutrition, and/or anemia associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce rectal pain, joint pain, constant need to poop, chronic fatigue, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD research study is testing a potential new medication to see if it may reduce stomach pain, stomach pain, constant need to poop, chronic fatigue, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.